Skip to main content

Table 3 List of 19 down regulated serum miRNAs in NSCLC patients compared to control subjects

From: MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients

mi RNA

Log (fold change) (mean ± sd)

p value

Control

NSCLC patients

miR-16-5b

0.22 ± 0.01

0.03 ± 0.01

0.001*

miR-17b-5p

3.05 ± 0.02

2.40 ± 18

0.001*

miR-19-3p

± 2.170.07

− 0.02 ± 0.012

0.001*

miR-20a-5p

0.19 ± 0.06

− 0.18 ± 0.017

0.001*

miR-339-5p

0.53 ± 0.29

0.06 ± 0.02

0.001*

miR-146a

0.55 ± 0.02

0.05 ± 0.03

0.001*

let-7 g

0.55 ± 0.03

0.08 ± 0.03

0.001*

let-7a

5.16 ± 0.09

2.42 ± 0.37

0.001*

let-7c

6.92 ± 0.01

3.05 ± 0.03

0.001*

let-7e

7.41 ± 0.82

3.80 ± 0.04

0.001*

let-7f

0.34 ± 0.08

− 0.04 ± 0.03

0.001*

let-7d

4.77 ± 0.23

1.52 ± 0.19

0.001*

let-7i

0.93 ± 0.03

0.37 ± 0.05

0.001*

miR-15a

0.20 ± 0.25

− 0.01 ± 0.002

0.001*

195 MiR-

0.22 ± 0.03

− 0.04 ± 0.03

0.001*

miR-98

1.31 ± 0.14

− 0.05 ± 0.03

0.001*

miR20b

0.31 ± 0.07

− 0.19 ± 0.10

0.001*

miR-126-

0.24 ± 0.06

− 0.06 ± 0.03

0.001*

miR-486-5p

4.49 ± 0.14

2.40 ± 0.16

0.001*

  1. *Significant t test